Authors:
BANKER AS
BERGERONLYNN G
KEEFE KS
DECLERCQ E
TASKINTUNA I
FREEMAN WR
Citation: As. Banker et al., EFFECTS OF TOPICAL AND SUBCONJUNCTIVAL CIDOFOVIR (HPMPC) IN AN ANIMAL-MODEL, Current eye research, 17(6), 1998, pp. 560-566
Authors:
BANKER AS
DECLERCQ E
TASKINTUNA I
KEEFE KS
BERGERONLYNN G
FREEMAN WR
Citation: As. Banker et al., INFLUENCE OF INTRAVITREAL INJECTIONS OF HPMPC AND RELATED NUCLEOSIDE ANALOGS ON INTRAOCULAR-PRESSURE IN GUINEA-PIG EYES, Investigative ophthalmology & visual science, 39(7), 1998, pp. 1233-1242
Authors:
TASKINTUNA I
BANKER AS
FLORESAGUILAR M
BERGERONLYNN G
ALDERN KA
HOSTETLER KY
FREEMAN WR
Citation: I. Taskintuna et al., EVALUATION OF A NOVEL LIPID PRODRUG FOR INTRAOCULAR DRUG-DELIVERY - EFFECT OF ACYCLOVIR DIPHOSPHATE DIMYRISTOYLGLYCEROL IN A RABBIT MODEL WITH HERPES-SIMPLEX VIRUS-1 RETINITIS, Retina, 17(1), 1997, pp. 57-64
Authors:
CHENG LY
HOSTETLER KY
ALDEM KA
GARDNER MF
AVILA CP
BERGERONLYNN G
MUNGUIA D
FREEMAN WR
Citation: Ly. Cheng et al., INTRAVITREAL TOXICOLOGY IN RABBITS OF THE 1-O-OCTADECYL-SN-GLYCEROL-3-PHOSPHONOFORMATE (ODG-PFA) ITS CARBOXYMETHYL ESTER, Investigative ophthalmology & visual science, 38(4), 1997, pp. 1015-1015
Authors:
TASKINTUNA I
BANKER AS
RAO NA
WILEY CA
FLORESAGUILAR M
MUNGUIA D
BERGERONLYNN G
DECLERCQ E
KEEFE K
FREEMAN WR
Citation: I. Taskintuna et al., AN ANIMAL-MODEL FOR CIDOFOVIR (HPMPC) TOXICITY - INTRAOCULAR-PRESSUREAND HISTOPATHOLOGIC EFFECTS, Experimental Eye Research, 64(5), 1997, pp. 795-806
Authors:
BANKER AS
TASKINTUNA I
DECLERCQ E
BERGERONLYNN G
CHANDLER B
FREEMAN WR
Citation: As. Banker et al., INFLUENCE OF INTRAVITREAL INJECTIONS OF HPMPC-RELATED NUCLEOTIDE ANALOGS ON INTRAOCULAR-PRESSURE OF GUINEA-PIG EYES, Investigative ophthalmology & visual science, 37(3), 1996, pp. 3548-3548
Authors:
KUPPERMANN BD
ASSIL KK
VUONG C
BESEN G
WILEY CA
DECLERCQ E
BERGERONLYNN G
CONNOR JD
PURSLEY M
MUNGUIA D
FREEMAN WR
Citation: Bd. Kuppermann et al., LIPOSOME-ENCAPSULATED (S)-1-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL) FORLONG-ACTING THERAPY OF VIRAL RETINITIS, The Journal of infectious diseases, 173(1), 1996, pp. 18-23
Authors:
BESEN G
CHAVEZDELAPAZ E
TATEBAYASHI M
FLORESAGUILAR M
GANGAN PA
MUNGUIA D
WILEY CA
JAHNE G
WINKLER I
HELSBERG M
BERGERONLYNN G
FREEMAN WR
Citation: G. Besen et al., EVALUATION OF RETINAL TOXICITY AND EFFICACY OF THE ANTICYTOMEGALOVIRUS COMPOUND 2-AMINO-7-[(1,3-DIHYDROXY-2-PROPOXY)METHYL]PURINE, Antimicrobial agents and chemotherapy, 39(7), 1995, pp. 1485-1488
Authors:
AREVALO JF
GONZALEZ C
CAPPARELLI EV
KIRSCH LS
GARCIA RP
QUICENO JI
CONNOR JD
GAMBERTOGLIO J
BERGERONLYNN G
FREEMAN WR
Citation: Jf. Arevalo et al., INTRAVITREOUS AND PLASMA-CONCENTRATIONS OF GANCICLOVIR AND FOSCARNET AFTER INTRAVENOUS THERAPY IN PATIENTS WITH AIDS AND CYTOMEGALOVIRUS RETINITIS, The Journal of infectious diseases, 172(4), 1995, pp. 951-956
Authors:
TATEBAYASHI M
NEYTS J
BESEN G
FLORESAGUILAR M
SMITH IL
WILEY CA
SPECTOR SA
BERGERONLYNN G
MAUDGAL PC
DECLERCQ E
GANGAN PA
CHAVEZ E
RUSSACK V
FREEMAN WR
Citation: M. Tatebayashi et al., ABSENCE OF INFECTIOUS RETINITIS AFTER INJECTION OF HUMAN CYTOMEGALOVIRUS INTO RABBIT EYES, The Journal of infectious diseases, 171(4), 1995, pp. 782-787
Authors:
BESEN G
FLORESAGUILAR M
ASSIL KK
KUPPERMAN BD
GANGAN P
PURSLEY M
MUNGUIA D
VUONG C
DECLERCQ E
BERGERONLYNN G
AZEN SP
FREEMAN WR
Citation: G. Besen et al., LONG-TERM THERAPY FOR HERPES RETINITIS IN AN ANIMAL-MODEL WITH HIGH-CONCENTRATED LIPOSOME-ENCAPSULATED HPMPC, Archives of ophthalmology, 113(5), 1995, pp. 661-668
Authors:
GANGAN PA
FLORESAGUILAR M
BESEN G
KIRSCH LS
WILEY CA
TATEBAYASHI M
BERGERONLYNN G
CHANDLER BA
KWAN MK
FREEMAN WR
Citation: Pa. Gangan et al., SUBRETINAL IMPLANTATION OF A BIODEGRADABLE MEMBRANE, Investigative ophthalmology & visual science, 35(4), 1994, pp. 1335-1335
Authors:
AREVALO JF
GONZALEZ C
KIRSCH LS
GARCIA R
QUICENO JI
CONNOR JD
GAMBERTOGLIO J
CAPPARELLI E
SHERWOOD CH
BERGERONLYNN G
FREEMAN WR
Citation: Jf. Arevalo et al., INTRAVITREAL ANTIVIRAL DRUG CONCENTRATION AFTER INTRAVENOUS GANCICLOVIR AND FOSCARNET IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME PATIENTS WITH CYTOMEGALOVIRUS RETINITIS, Investigative ophthalmology & visual science, 35(4), 1994, pp. 1892-1892
Authors:
BESEN G
JAHNE G
WINKLER I
HELSBERG M
FLORESAGUILAR M
TATEBAYASHI M
GANGAN P
DELAPAZ EC
MUNGUIA D
CHANDLER B
BERGERONLYNN G
FREEMAN WR
Citation: G. Besen et al., EVALUATION OF RETINAL TOXICITY AND EFFICACY OF THE ANTI-CMV COMPOUND 2-AMINO-7-[(1,3-DIHIDROXY-2-PROPOXY) METHYL] PURINE (COMPOUND-I), Investigative ophthalmology & visual science, 35(4), 1994, pp. 2102-2102
Authors:
MUNGUIA HD
SHAKIBA S
FLORESAGUILAR M
BESEN G
TATEBAYASHI M
BERGERONLYNN G
SRIDHAR CN
GARDNER MF
HOSTETLER KY
FREEMAN WR
Citation: Hd. Munguia et al., INTRAVITREAL PHARMACOKINETIC STUDY OF ACYCLOVIR DIPHOSPHATE DIMYRISTOYLGLYCEROL (ACVDP-DMG) - A PROMISING LIPOSOME PRO-DRUG FOR HUMAN CYTOMEGALOVIRUS (HCMV) RETINITIS, Investigative ophthalmology & visual science, 35(4), 1994, pp. 2104-2104
Authors:
FLORESAGUILAR M
HUANG JS
WILEY CA
DECLERCQ E
VUONG C
BERGERONLYNN G
CHANDLER B
MUNGUIA D
FREEMAN WR
Citation: M. Floresaguilar et al., LONG-ACTING THERAPY OF VIRAL RETINITIS WITH S)-1-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL)CYTOSINE, The Journal of infectious diseases, 169(3), 1994, pp. 642-647
Authors:
SHAKIBA S
ASSIL KK
LISTHAUS AD
MUNGUIA D
FLORESAGUILAR M
VUONG C
WILEY CA
TOLMAN RL
KARKAS JD
BERGERONLYNN G
FREEMAN WR
Citation: S. Shakiba et al., EVALUATION OF RETINAL TOXICITY AND LIPOSOME ENCAPSULATION OF THE ANTI-CMV DRUG 2'-NOR-CYCLIC GMP, Investigative ophthalmology & visual science, 34(10), 1993, pp. 2903-2910